AcelRx Pharmaceuticals Announces Closing of Previously Announced Private Placement Priced At-The-Market Under Nasdaq Rules

Provided By PR Newswire

Last update: Jul 21, 2023

Transformative capital raise, led by new investors including Nantahala Capital Management

The private placement provides access to up to $26.3 million of gross proceeds upon the exercise of the milestone-affected warrants